AIG
GNCA

American International Group’s Genocea Biosciences, Inc. GNCA Stock Holding History

American International Group’s Portfolio GNCA Stock Details GNCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-6,588
Closed -$55K – 3165
2018
Q1 		$55K Buy
6,588
+4,177
+173% +$34.7K ﹤0.01% 2885
2017
Q4 		$22K Buy
2,411
+11
+0.5% +$111 ﹤0.01% 3012
2017
Q3 		$28K Buy
2,400
+179
+8% +$6.79K ﹤0.01% 2823
2017
Q2 		$93K Buy
+2,221
New +$107K ﹤0.01% 2774
2016
Q2 		– Sell
-1,360
Closed -$84K – 4791
2016
Q1 		$84K Hold
1,360
– – ﹤0.01% 3566
2015
Q4 		$57K Sell
1,360
-3
-0.2% -$143 ﹤0.01% 3854
2015
Q3 		$75K Buy
1,363
+2
+0.1% +$198 ﹤0.01% 3711
2015
Q2 		$149K Buy
1,361
+1,054
+343% +$97.9K ﹤0.01% 3287
2015
Q1 		$29.1K Hold
307
– – ﹤0.01% 4202
2014
Q4 		$17.2K Sell
307
-12
-4% -$820 ﹤0.01% 4388
2014
Q3 		$23.1K Hold
319
– – ﹤0.01% 4276
2014
Q2 		$47.9K Buy
+319
New +$48.4K ﹤0.01% 3980

Other funds holding GNCA

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

American International Group's GNCA Position: Q2 2018 in Review

American International Group sold out of Genocea Biosciences, Inc. (GNCA) in Q2 2018, closing a stake of 6,588 shares — an estimated $55K sold.

American International Group first reported a position in GNCA in Q2 2014 and held it in 12 quarters. The position peaked at $149K in Q2 2015. 54 funds tracked by Wall St. Rank hold GNCA as of Q2 2018.

  • American International Group reported no remaining Genocea Biosciences, Inc. position as of Q2 2018 after selling out during the quarter.
  • American International Group sold 6,588 Genocea Biosciences, Inc. shares in Q2 2018, an estimated $55K.
  • American International Group first reported a position in Genocea Biosciences, Inc. in Q2 2014 and held it in 12 quarters.
  • American International Group's Genocea Biosciences, Inc. position peaked at $149K in Q2 2015.
  • 54 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q2 2018.

Based on American International Group's 13F filing for Q2 2018, filed 8 Aug 2018.